Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...
Around 20% to 25% of individuals with rapidly declining FEV1/FVC trajectories experienced wheezing and usual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback